83
Participants
Start Date
September 30, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
March 31, 2014
SPI-1005 Low dose
Oral capsules, 200 mg ebselen, twice daily, 4 days
SPI-1005 Middle dose
Oral capsules, 400 mg ebselen, twice daily, 4 days
SPI-1005 High dose
Oral capsules, 600 mg ebselen, twice daily, 4 days
Placebo
Oral capsules, 0 mg ebselen, twice daily, 4 days
University of Florida, Gainsville
University of Florida
OTHER
Sound Pharmaceuticals, Incorporated
INDUSTRY